risksales

370 results found.

Top Stocks matching your search for "risk sales"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
BABA

Alibaba Group Holding Ltd - ADR

-20.42%

$105.11 - $83.65

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 13, 2023

Honestly $BABA equity offers pretty good risk vs r... See more

Jan, 20, 2023

Allowed longs to get into a risk free position.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 13, 2023

$AVXL At this level, the remaining float could eas... See more

Dec, 17, 2022

There is close to zero risk for that.

Motley Fool
Discover Your Wealth Potential with Stock Advisor

The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.

*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.
02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 14, 2023

This is a low risk HIGH REWARD here.

BABA

Alibaba Group Holding Ltd - ADR

-20.42%

$105.11 - $83.65

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 13, 2023

Honestly $BABA equity offers pretty good risk vs reward down here Could be a solid winner into Q2 & Q3 as China continues its reopening, and looks to be completing a deep retracement after pulling back from recent swing highs

Jan, 20, 2023

Allowed longs to get into a risk free position.

Jan, 17, 2023

Zero risk only gains every pile in

Jan, 14, 2023

Invest now, or risk sitting off to the side with envy.

Jan, 13, 2023

There wasn’t any downside risk anymore, so i went all-in on calls, and it changed my life.

Jan, 13, 2023

No delist risk. 9.

Dec, 21, 2022

But they mention big ones like $BABA or $KWEB I like this small ones that have huge asset value, therefore very small downside risk.

Dec, 15, 2022

$BABA risk reward getting much more attractive now that another headwind is easing.

Dec, 13, 2022

I just love baba and I understand the issues in China and the risk,

Nov, 30, 2022

$SPY BULLISH RISK ON $TSLA $AAPL $BABA

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 13, 2023

$AVXL At this level, the remaining float could easily get locked up by institutional investors and they will likely come in the next days/weeks for this very high reward / low risk company.

Dec, 17, 2022

There is close to zero risk for that.

Dec, 12, 2022

$AVXL There is no risk of meeting the end points and safety and other unknowns or delays.

Dec, 9, 2022

Worth the risk with patience and not investing lifestyle or bill money.

Dec, 8, 2022

My risk is worth it if other pump.

Dec, 1, 2022

From the perspective of long only DCA, risk reward here is significant. #nostoploss

Dec, 1, 2022

Maybe worth paying more for lower risk.

Nov, 19, 2022

I like the bet & risk:reward and the science, will make it every time (esp w/all house money at this point)🤷‍♂️

Oct, 26, 2022

minimizes risk and allows for accumulation over time before the REAL money is made.

Oct, 18, 2022

So this is the best risk to reward investment you will see in your lifetime.

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 14, 2023

This is a low risk HIGH REWARD here.